AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $693,000 | -94.8% | 965,800 | -83.7% | 0.03% | -93.4% |
| Q4 2021 | $13,376,000 | -6.7% | 5,918,565 | +18.9% | 0.47% | +4.2% |
| Q3 2021 | $14,337,000 | -26.8% | 4,978,195 | -3.7% | 0.45% | -18.9% |
| Q2 2021 | $19,595,000 | +12.4% | 5,170,063 | +0.4% | 0.56% | +9.2% |
| Q1 2021 | $17,436,000 | -11.6% | 5,150,819 | -26.8% | 0.51% | -16.5% |
| Q4 2020 | $19,713,000 | +36.7% | 7,040,487 | +22.5% | 0.61% | +38.5% |
| Q3 2020 | $14,424,000 | -82.6% | 5,746,623 | -5.8% | 0.44% | -82.3% |
| Q2 2020 | $82,853,000 | +66.6% | 6,101,111 | -7.0% | 2.50% | +34.2% |
| Q1 2020 | $49,721,000 | +16.8% | 6,559,478 | -2.6% | 1.86% | +41.9% |
| Q4 2019 | $42,579,000 | +39.4% | 6,737,120 | -13.5% | 1.31% | +15.9% |
| Q3 2019 | $30,535,000 | -19.0% | 7,789,561 | 0.0% | 1.13% | -2.5% |
| Q2 2019 | $37,701,000 | -6.8% | 7,789,561 | +57.6% | 1.16% | -8.0% |
| Q1 2019 | $40,467,000 | +33.6% | 4,941,061 | -9.8% | 1.26% | +35.4% |
| Q4 2018 | $30,293,000 | -38.5% | 5,478,089 | -1.7% | 0.93% | -29.6% |
| Q3 2018 | $49,230,000 | -8.2% | 5,575,211 | +3.7% | 1.32% | -39.0% |
| Q2 2018 | $53,634,000 | +52.7% | 5,374,111 | +45.8% | 2.17% | +37.2% |
| Q1 2018 | $35,129,000 | +22.2% | 3,686,143 | +90.6% | 1.58% | +23.9% |
| Q4 2017 | $28,757,000 | +6.9% | 1,933,867 | +41.4% | 1.28% | -3.1% |
| Q3 2017 | $26,908,000 | -12.9% | 1,367,947 | -36.3% | 1.32% | -46.2% |
| Q2 2017 | $30,876,000 | +47.2% | 2,148,623 | -5.8% | 2.45% | +4.8% |
| Q1 2017 | $20,981,000 | -9.7% | 2,280,531 | +2.2% | 2.34% | -3.1% |
| Q4 2016 | $23,239,000 | +34.1% | 2,232,408 | +16.6% | 2.41% | +15.4% |
| Q3 2016 | $17,331,000 | +37.9% | 1,915,008 | +14.0% | 2.09% | +53.3% |
| Q2 2016 | $12,569,000 | +3.5% | 1,680,390 | +24.7% | 1.36% | +9.1% |
| Q1 2016 | $12,139,000 | +323.8% | 1,347,326 | +507.8% | 1.25% | +234.0% |
| Q4 2015 | $2,864,000 | – | 221,674 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 16,205,119 | $18,473,836 | 31.57% |
| ACADIAN ASSET MANAGEMENT LLC | 7,223,488 | $8,233 | 0.04% |
| Orchard Capital Management, LLC | 66,826 | $76,182 | 0.03% |
| XTX Topco Ltd | 138,506 | $157,897 | 0.03% |
| State of Wyoming | 74,010 | $84,371 | 0.02% |
| WEALTH EFFECTS LLC | 29,500 | $33,630 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,719,061 | $1,959,730 | 0.01% |
| James J. Burns & Company, LLC | 24,542 | $28 | 0.01% |
| Eudaimonia Partners, LLC | 27,144 | $30,945 | 0.01% |
| SYKON CAPITAL LLC | 15,000 | $17,100 | 0.01% |